Sanofi-Aventis Keeps Optimedia

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

French pharmaceutical giant Sanofi-Aventis has opted to retain Publicis Groupe’s Optimedia for global media chores after a review, according to sources.

Estimated worldwide spending on the account is $450 million.

In the U.S., the company spent $210 million in measured media, excluding digital, in 2009, down 15 percent from $245 million in ’08, according to Nielsen.

Through the first seven months of this year, Sanofi-Aventis spent $90 million on domestic ads, per Nielsen.

Other contenders were not immediately known, although the company is believed to have contacted the major holding companies during the process.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in